People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, researchers reported Jan. 20 in The Lancet Rheumatology. Currently, no ...

Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

An implantable vagus nerve stimulation device yielded an ACR20 response rate of more than 52% at 12 months in patients with rheumatoid arthritis, according to findings published in Nature ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

Treatments and outcomes for rheumatoid arthritis (RA) have made major advances in the last decade. Earlier diagnoses, better treatment strategies, and improvements in disease modifying anti-rheumatic ...

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

The discovery and introduction of corticosteroid therapy by Philip Hench in the late 1940s and early 1950s was a seminal advance in the treatment of inflammatory diseases, including rheumatoid ...

Ongoing pain, swelling, stiffness and fatigue are all symptoms that might push anyone to talk to their doctor, get a diagnosis and find the right treatment plan. But, when that diagnosis is a chronic ...